The CAN.HEAL project will build on distinct use cases towards developing an integrated approach to improve access of individuals and cancer patients and survivors to prevention- diagnosis and treatment of cancer through personalised medicine. Building the EU Cancer and Public Health Genomics platform.

Project description

The CAN.HEAL consortium will address two of the EBCP’s initiatives: ‘Cancer Diagnostic and Treatment for All’ and ‘Genomics for Public Health’. Genomics has become increasingly relevant in cancer medicine. Next-generation sequencing technologies and analytical approaches are now being introduced into the clinic with a multitude of clinical applications- ranging from identifying individual targetable genetic alterations to monitoring treatment response. Within the CAN.HEAL consortium organisations from 17 EU countries will jointly build on ongoing studies to promote the application of genomics to improve diagnosis and treatment of cancer patients as well as to improve our understanding of the individual susceptibility to develop a certain type of cancer.

The final goal of the project is to establish recommendations for initiatives into the EU health system that will further improve the access of individuals and patients to prevention- diagnosis and treatment of cancer through personalised medicine.